Log In
Print
BCIQ
Print
Print this Print this
 

PledOx, calmangafodipir

  Manage Alerts
Collapse Summary General Information
Company PledPharma AB
DescriptionPyridoxyl ethyldiamine (PLED) analog in which 80% of the manganese in the MRI contrast agent mangafodipir has been replaced by calcium
Molecular Target Superoxide dismutase 2 mitochondrial (SOD2) (MNSOD)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today